Cancer Therapy Evaluation Program
BRB investigators Drs. Edward Korn, Larry Rubinstein, Boris Freidlin, and Sally Hunsberger collaborate extensively with the Cancer Therapy Evaluation Program (CTEP). These activities include statistical review of all CTEP-sponsored clinical trials, service on Data Safety Monitoring Committees of the cooperative oncology groups, participation on the investigational drug and disease area steering committees and task forces, and participation in the design of clinical trials for the development and evaluation of investigational drugs.
Richard Simon, D.Sc., leads the Biometric Research Program and is chief of the Computational & Systems Biology Branch. Dr. Simon holds a doctoral degree in Applied Mathematics & Computer Science from Washington University in St. Louis, MO. More…